These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 9698512)
1. Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients. Schweitzer EJ; Yoon S; Fink J; Wiland A; Anderson L; Kuo PC; Lim JW; Johnson LB; Farney AC; Weir MR; Bartlett ST Transplantation; 1998 Jan; 65(2):242-8. PubMed ID: 9458022 [TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Neylan JF Transplantation; 1997 Nov; 64(9):1277-82. PubMed ID: 9371668 [TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes. David KM; Morris JA; Steffen BJ; Chi-Burris KS; Gotz VP; Gordon RD Clin Transplant; 2005 Apr; 19(2):279-85. PubMed ID: 15740568 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of therapeutic effects of prednisone combined with mycophenolate mofetil versus cyclosporin A in children with steroid-resistant nephrotic syndrome]. Li ZH; Lin Z; Duan CR; Wu TH; Xun M; Zhang Y; Zhang L; Ding YF; Yin Y Zhongguo Dang Dai Er Ke Za Zhi; 2016 Feb; 18(2):130-5. PubMed ID: 26903059 [TBL] [Abstract][Full Text] [Related]
6. Pediatric Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Retrospective Cohort Study Using Real-World Evidence From the US Scientific Registry of Transplant Recipients. Erdman J; Wolfram J; Nimke D; Croy R; Wang X; Weaver T; Schladt D; Fitzsimmons WE Transplant Proc; 2023 Sep; 55(7):1692-1705. PubMed ID: 37438193 [TBL] [Abstract][Full Text] [Related]
7. Serum Selenium, Iron, Zinc, and Copper Concentrations in Renal Transplant Recipients Treated with Mycophenolate Mofetil. Wilk A; Szypulska-Koziarska D; Marchelek-Myśliwiec M; Głazek W; Wiszniewska B Biol Trace Elem Res; 2020 Dec; 198(2):371-379. PubMed ID: 32072447 [TBL] [Abstract][Full Text] [Related]
8. Association of mycophenolate and azathioprine use with cognitive function in systemic lupus. Dobrowolski C; McGinley J; Fazzari M; Su J; Bingham KS; Anderson N; Ruttan L; Beaton DE; Wither JE; Tartaglia MC; Kakvan M; Bonilla D; Choi MY; Fritzler MJ; Diaz Martinez JP; Katz P; Green R; Putterman C; Touma Z Rheumatology (Oxford); 2023 May; 62(5):1860-1869. PubMed ID: 36135792 [TBL] [Abstract][Full Text] [Related]
9. Data mining and safety analysis of traditional immunosuppressive drugs: a pharmacovigilance investigation based on the FAERS database. Li JJ; Chen L; Zhao Y; Yang XQ; Hu FB; Wang L Expert Opin Drug Saf; 2024 Apr; 23(4):513-525. PubMed ID: 38533933 [TBL] [Abstract][Full Text] [Related]
10. Long-term results of cyclosporine-steroid therapy in 131 non-matched cadaveric renal transplants. Gordon RD; Starzl TE; Hakala TR; Taylor RJ; Schroter GP; Rosenthal JT; Well R; Iwatsuki S; Carpenter BJ Clin Transplant; 1987; 1(1):44-48. PubMed ID: 21151803 [TBL] [Abstract][Full Text] [Related]
11. The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system. Shapiro R; Tzakis AG; Fung JJ; Hakala TR; Jordan ML; Hickey D; Iwaki Y; Starzl TE Clin Transpl; 1989; ():287-93. PubMed ID: 2487574 [TBL] [Abstract][Full Text] [Related]
12. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence. Pham PT; Pham PC Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415 [TBL] [Abstract][Full Text] [Related]
14. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347 [TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review. Knight SR; Russell NK; Barcena L; Morris PJ Transplantation; 2009 Mar; 87(6):785-94. PubMed ID: 19300178 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systematic review. Wang K; Zhang H; Li Y; Wei Q; Li H; Yang Y; Lu Y Transplant Proc; 2004 Sep; 36(7):2071-2. PubMed ID: 15518749 [TBL] [Abstract][Full Text] [Related]
17. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine. Lee CM; Markezich AJ; Scandling JD; Dafoe DC; Alfrey EJ J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512 [TBL] [Abstract][Full Text] [Related]